FDA Approves Unknown Drug — AUROBINDO PHARMA USA

# FDA Approves Aurobindo Pharma USA Generic Drug Application Aurobindo Pharma USA received FDA approval for ANDA 077873 on June 29, 2007, expanding the company's generic drug portfolio and positioning it to capture additional market share in the competitive U.S. pharmaceutical market. The approval strengthens Aurobindo's presence as a major generic drug supplier and enhances its ability to offer cost-effective alternatives to branded medications.